EcoDrugPlus

Carbonic Anhydrase 14

Ensembl ID : ENSBSLG00000023965
Gene Symbol: CA14
3 Cross references
211 Possible Orthologues:

Carbonic Anhydrase 4-Like

Ensembl ID : ENSBSLG00000019727
Gene Symbol: LOC114869766
3 Cross references
215 Possible Orthologues:

Carbonic Anhydrase 4-Like

Ensembl ID : ENSBSLG00000010135
Gene Symbol: LOC114869954
3 Cross references
201 Possible Orthologues:

Carbonic Anhydrase 4-Like

Ensembl ID : ENSBSLG00000009682
Gene Symbol: LOC114868064
3 Cross references
198 Possible Orthologues:

Carbonic Anhydrase 5a

Ensembl ID : ENSBSLG00000018109
Gene Symbol: CA5A
3 Cross references
231 Possible Orthologues:

Carbonic Anhydrase 6

Ensembl ID : ENSBSLG00000007307
Gene Symbol: CA6
3 Cross references
227 Possible Orthologues:

Carbonic Anhydrase 7

Ensembl ID : ENSBSLG00000000910
Gene Symbol: CA7
3 Cross references
222 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSBSLG00000016312
Gene Symbol: CSNK1E
3 Cross references
199 Possible Orthologues:

Casein Kinase I-Like

Ensembl ID : ENSBSLG00000019909
Gene Symbol: LOC114846190
3 Cross references
205 Possible Orthologues:

Caspase 9

Ensembl ID : ENSBSLG00000001736
Gene Symbol: CASP9
3 Cross references
204 Possible Orthologues:

Catechol-O-Methyltransferase

Ensembl ID : ENSBSLG00000010327
Gene Symbol: COMT
3 Cross references
215 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSBSLG00000015887
Gene Symbol: CTSC
3 Cross references
239 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).